The IRWD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the IRWD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The IRWD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View IRWD Detailed Price Forecast - CNN Money | View IRWD Detailed Summary - Google Finance | ||
View IRWD Detailed Summary - Yahoo! Finance | View IRWD Stock Research & Analysis - Zacks.com |
View IRWD Trends & Analysis - Trade-Ideas | View IRWD Major Holders - Barrons | ||
View IRWD Call Transcripts - NASDAQ | View IRWD Breaking News & Analysis - Seeking Alpha | ||
View IRWD Annual Report - CompanySpotlight.com | View IRWD OTC Short Report - OTCShortReport.com | ||
View IRWD Fundamentals - TradeKing | View IRWD SEC Filings - Bar Chart | ||
View Historical Prices for IRWD - The WSJ | View Performance/Total Return for IRWD - Morningstar | ||
View the Analyst Estimates for IRWD - MarketWatch | View the Earnings History for IRWD - CNBC | ||
View the IRWD Earnings - StockMarketWatch | View IRWD Buy or Sell Recommendations - MacroAxis | ||
View the IRWD Bullish Patterns - American Bulls | View IRWD Short Pain Metrics - ShortPainBot.com |
View IRWD Stock Mentions - StockTwits | View IRWD Stock Mentions - PennyStockTweets | ||
View IRWD Stock Mentions - Twitter | View IRWD Investment Forum News - Investor Hub | ||
View IRWD Stock Mentions - Yahoo! Message Board | View IRWD Stock Mentions - Seeking Alpha |
View Insider Transactions for IRWD - SECform4.com | View Insider Transactions for IRWD - Insider Cow | ||
View IRWD Major Holdings Summary - CNBC | View Insider Disclosure for IRWD - OTC Markets | ||
View Insider Transactions for IRWD - Yahoo! Finance | View Institutional Holdings for IRWD - NASDAQ |
View IRWD Stock Insight & Charts - FinViz.com | View IRWD Investment Charts - StockCharts.com | ||
View IRWD Stock Overview & Charts - BarChart | View IRWD User Generated Charts - Trading View |
Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
Posted on Thursday April 25, 2024
BOSTON, April 25, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its first quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, May 9, 2024. Individuals interested in participating in the call should dial (888) 596-4144 (U.S. and Canada) or (646) 968-2525 (international) using conference ID number and event passcode 3416473. To access the webcast, please visit the Investors section of Ironwood’s website at www.ironwoodp
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
Posted on Monday March 25, 2024
OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.
It’s Time! 3 Failing Biotech Stocks to Sell Right Now
Posted on Tuesday March 05, 2024
Healthcare stocks, especially biotech companies, are very risky for investors. Their share price can be highly volatile and surge higher or plummet lower based on news regarding a clinical trial, treatment authorization, or any number of events that could be or break a company. In other industries, this massive shift in price action isn’t nearly as prevalent. Some biotech companies are failing and won’t offer investors much in the way of returns. And they should be ditched from any watchlist bec
Ironwood Pharmaceuticals Ran Up 38% Over Three Months — And Just Lost It All
Posted on Thursday February 29, 2024
Shares of Ironwood Pharmaceuticals collapsed Thursday on mixed results for its gastrointestinal drug. The biotech stock erased a 38% gain.